Cue Biopharma in $374M-plus Merck immunotherapy pact – FierceBiotech
FierceBiotechCue Biopharma in $374M-plus Merck immunotherapy pactFierceBiotechAfter raising $26 million at the start of the year, cancer and autoimmune startup Cue Biopharma has ended the year with a potentially lucrative new deal with Merck. Financial… Continue reading
